Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Trifluoromethyl Quinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed carbonylation route for quinazolinones. High yield, scalable process for drug molecules like Rutaecarpine.
Patent CN112480015B details a scalable one-pot method for 2-trifluoromethyl quinazolinones, offering cost reduction in pharmaceutical intermediate manufacturing via safe carbonylation.
Patent CN112480015B reveals a Pd-catalyzed one-pot method for quinazolinones. Offers cost-effective, scalable routes for API intermediates.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN111675662B reveals a scalable iron-catalyzed route to 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones. High efficiency, broad substrate scope, cost-effective manufacturing for pharmaceutical intermediates.
Novel one-pot method for 2-trifluoromethyl quinazolinones using nitro compounds. High yield, scalable process for pharmaceutical intermediates.
Patent CN112480015B details a Pd-catalyzed carbonylation method for quinazolinones. Offers high yield, mild conditions, and scalable routes for API intermediates.
Patent CN112480015B details a novel one-pot carbonylation method for high-purity quinazolinone intermediates, offering significant cost reduction and scalability for API manufacturing.
Patent CN113045503B details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112480015B reveals a Pd-catalyzed one-pot method for quinazolinones, offering cost-effective routes for API manufacturing and reliable supply chain solutions.
Patent CN112125856A reveals a safe palladium-catalyzed route to 2-trifluoromethyl quinazolinones using solid CO surrogates, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN112480015B details a novel one-pot synthesis of 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction in API manufacturing.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for quinazolinones. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for API manufacturing.
Patent CN112480015B reveals a novel one-pot method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112480015B details a novel one-pot synthesis for 2-trifluoromethyl quinazolinones using nitro compounds, offering cost-effective routes for pharmaceutical intermediate manufacturing.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply chain solutions.
Novel FeCl3-catalyzed cyclization method offers high yields and cost-effective production for pharmaceutical intermediates.
Novel Pd-catalyzed one-pot method offers cost-effective route for high-purity quinazolinone APIs with broad substrate tolerance.